Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Cervical Cancer | Research

Barriers and facilitators in cervical cancer screening uptake in Abidjan, Côte d'Ivoire in 2018: a cross-sectional study

Authors: Simon P. Boni, Franck Gnahatin, Jean-Claude Comoé, Boris Tchounga, Didier Ekouevi, Apollinaire Horo, Innocent Adoubi, Antoine Jaquet

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Backgrounds

Cervical cancer (CC) incidence remains unacceptably high in Côte d’Ivoire. In an effort to prevent this malignant condition, a national CC screening program has been scaled up in the country. This study aimed at assessing CC screening uptake and its associated factors in Abidjan in 2018.

Methods

A cross-sectional survey was conducted from July to September 2018 in the main healthcare facilities of three randomly selected out of the eight health districts of Abidjan. During the study period, a standardized questionnaire was administrated by research assistants to all women aged 25 to 55 years old, attending the three participating facilities. Demographics, knowledge on CC, personal history of CC screening and reasons for not attending CC screening were collected. A logistic regression model was computed to document factors associated with reported CC screening uptake.

Results

A total of 1158 women with a median age of 32 years (IQR [27–36]), including 364 (31.4%) with no formal education were included. Of those participants, 786 (67.9%) had ever heard about CC. CC screening uptake at least once was reported by 7.5% [95% CI: 6.0–9.0] participants. In multivariable analysis, being ≥45 years (aOR: 6.2 [2.3–17.2]), having a university level (aOR: 2.8 [1.2–6.6]) (versus non formal education) and access to mass campaign information (aOR: 18.2 [8.5–39.1]) were associated with a reported CC screening uptake. The main reported barriers to CC screening were unawareness towards CC screening (75.5%), negligence (20.5%), fear of CC detection (3.9%) and fear of additional costs (3.3%).

Conclusion

CC screening uptake remains low despite current initiatives to support awareness and prevention in Abidjan. Awareness campaigns need to be massively increased with the adjunction of tailored messages based on the level of women’s education to enhance the CC screening coverage and reach the WHO goal of CC elimination by 2030.
Literature
2.
go back to reference Ngoma M, Autier P. Cancer prevention: cervical cancer. Ecancermedicalscience. 2019;13:952.CrossRef Ngoma M, Autier P. Cancer prevention: cervical cancer. Ecancermedicalscience. 2019;13:952.CrossRef
3.
go back to reference World Health Organization, editor. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization; 2013. p. 40. World Health Organization, editor. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization; 2013. p. 40.
6.
go back to reference Msyamboza KP, Phiri T, Sichali W, Kwenda W, Kachale F. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study. BMC Public Health. 2016;16(1):806.CrossRef Msyamboza KP, Phiri T, Sichali W, Kwenda W, Kachale F. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study. BMC Public Health. 2016;16(1):806.CrossRef
9.
go back to reference National Cancer Control Program. National guidelines for the cervical cancer prevention, Côte d'Ivoire. Côte d'Ivoire: National Cancer Control Program (NCCP); 2013. National Cancer Control Program. National guidelines for the cervical cancer prevention, Côte d'Ivoire. Côte d'Ivoire: National Cancer Control Program (NCCP); 2013.
13.
go back to reference Donatus L, Nina FK, Sama DJ, Nkfusai CN, Bede F, Shirinde J, et al. Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo west Health District, Cameroon. Pan Afr Med J. 2019;33:106.CrossRef Donatus L, Nina FK, Sama DJ, Nkfusai CN, Bede F, Shirinde J, et al. Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo west Health District, Cameroon. Pan Afr Med J. 2019;33:106.CrossRef
21.
go back to reference Ouedraogo Y, Furlane G, Fruhauf T, Badolo O, Bonkoungou M, Pleah T, et al. Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso. Glob Health Sci Pract. 2018;6(2):288–98.CrossRef Ouedraogo Y, Furlane G, Fruhauf T, Badolo O, Bonkoungou M, Pleah T, et al. Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso. Glob Health Sci Pract. 2018;6(2):288–98.CrossRef
Metadata
Title
Barriers and facilitators in cervical cancer screening uptake in Abidjan, Côte d'Ivoire in 2018: a cross-sectional study
Authors
Simon P. Boni
Franck Gnahatin
Jean-Claude Comoé
Boris Tchounga
Didier Ekouevi
Apollinaire Horo
Innocent Adoubi
Antoine Jaquet
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08650-6

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine